Subscribe to Daily Review - your favourite M&A deals update.

MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Katie Engleman
Katie Engleman1AB

Katie Engleman

Managing Director at 1AB

PR Consultant

Deal Bio

Total Deals11
Valued Deals10
Total Value£ 1.14 B
Avg. Deal Size£ 114 M

Market Context

Sort

08 Oct 2024|United States|Biotechnology
City Therapeutics
REGENERON

Target: CITY THERAPEUTICS

Bidder: REGENERON

4 Service Providers

3 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

£ 103 M

Value

07 Aug 2024|United States|Biotechnology
IDRX
Andreessen Horowitz (a16z)

Target: IDRX

Bidder: ANDREESSEN HOROWITZ LLC (A16Z)

12 Service Providers

2 Target | 10 Bidder

11 Dealmakers

2 Target | 9 Bidder

£ 94 M

Value

18 Jun 2024|United States|Biotechnology
Marea Therapeutics
Perceptive Xontogeny Venture Fund

Target: MAREA THERAPEUTICS

Bidder: PERCEPTIVE XONTOGENY VENTURE FUND

5 Service Providers

2 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 149 M

Value

05 Jan 2023|Denmark|Biotechnology
Twelve Bio
ENSOMA

Target: TWELVE BIO

Bidder: ENSOMA

4 Service Providers

1 Target | 3 Bidder

15 Dealmakers

1 Target | 14 Bidder

n/a

Value

05 Jan 2023|United States|Biotechnology
ENSOMA
Arix Bioscience

Target: ENSOMA

Bidder: ARIX BIOSCIENCE

19 Service Providers

3 Target | 16 Bidder

19 Dealmakers

3 Target | 16 Bidder

£ 108 M

Value

21 Nov 2022|United States|Biotechnology
FOGPHARMA
Gv (google Ventures)

Target: FOGPHARMA

Bidder: GV (GOOGLE VENTURES)

2 Service Providers

2 Target

3 Dealmakers

3 Target

£ 149 M

Value

11 Oct 2022|United States|Biotechnology
Neumora Therapeutics
Arch Venture Partners

Target: NEUMORA THERAPEUTICS

Bidder: ARCH VENTURE PARTNERS

11 Service Providers

2 Target | 9 Bidder

13 Dealmakers

4 Target | 9 Bidder

£ 101 M

Value

02 Aug 2022|United States|Biotechnology
IDRX
Casdin Capital

Target: IDRX

Bidder: CASDIN CAPITAL

8 Service Providers

2 Target | 6 Bidder

7 Dealmakers

3 Target | 4 Bidder

£ 99 M

Value

10 May 2022|United States|Biotechnology
Moma Therapeutics
Rock Springs Capital

Target: MOMA THERAPEUTICS

Bidder: ROCK SPRINGS CAPITAL

15 Service Providers

2 Target | 13 Bidder

14 Dealmakers

2 Target | 12 Bidder

£ 121 M

Value

10 Jan 2022|United States|Biotechnology
Maze Therapeutics
Driehaus Capital

Target: MAZE THERAPEUTICS

Bidder: DRIEHAUS CAPITAL

11 Service Providers

2 Target | 9 Bidder

12 Dealmakers

3 Target | 9 Bidder

£ 139 M

Value

07 Oct 2021|United States|Biotechnology
Neumora Therapeutics
Amgen

Target: NEUMORA THERAPEUTICS

Bidder: AMGEN INC

2 Service Providers

1 Target | 1 Bidder

6 Dealmakers

2 Target | 4 Bidder

£ 73 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite